Merging the properties of a sirolimus coated balloon with those of a bioresorbable polymer sirolimus eluting stent to address the "diabetes issue". Results from the En-Abl multicenter registry.
CONCLUSIONS: The performance of the Abluminus DES+ is consistent among patients with or without diabetes, regardless the insulin dependency.
PMID: 29687699 [PubMed - as supplied by publisher]
Source: Minerva Cardioangiologica - Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
More News: Angioplasty | Cardiology | Coronary Angioplasty | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Attack | India Health | Insulin | Percutaneous Coronary Intervention | Statistics | Thrombosis